Swiss National Bank Innoviva, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Innoviva, Inc. stock. As of the latest transaction made, Swiss National Bank holds 109,800 shares of INVA stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,800

Previous 111,900 1.88%

Holding current value

$1.94 Million

Previous $1.84 Million 15.48%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$16.33 - $20.04 $34,293 - $42,084	-2,100 Reduced 1.88%	109,800 $2.12 Million
Q2 2024 Aug 08, 2024	SELL	$14.4 - $16.4 $27,360 - $31,159	-1,900 Reduced 1.67%	111,900 $1.84 Million
Q1 2024 May 07, 2024	SELL	$14.56 - $16.78 $23,296 - $26,848	-1,600 Reduced 1.39%	113,800 $1.73 Million
Q4 2023 Feb 06, 2024	SELL	$12.32 - $16.27 $174,944 - $231,034	-14,200 Reduced 10.96%	115,400 $1.85 Million
Q3 2023 Nov 08, 2023	SELL	$12.37 - $13.89 $48,243 - $54,171	-3,900 Reduced 2.92%	129,600 $1.68 Million
Q2 2023 Aug 09, 2023	SELL	$11.39 - $13.72 $23,919 - $28,812	-2,100 Reduced 1.55%	133,500 $1.7 Million
Q1 2023 May 10, 2023	SELL	$10.73 - $13.6 $170,607 - $216,240	-15,900 Reduced 10.5%	135,600 $1.53 Million
Q4 2022 Feb 08, 2023	BUY	$11.8 - $13.78 $42,480 - $49,608	3,600 Added 2.43%	151,500 $2.01 Million
Q1 2022 May 09, 2022	BUY	$15.39 - $20.25 $156,978 - $206,550	10,200 Added 7.41%	147,900 $2.86 Million
Q4 2021 Feb 08, 2022	SELL	$15.91 - $18.72 $120,916 - $142,272	-7,600 Reduced 5.23%	137,700 $2.38 Million
Q2 2021 Aug 06, 2021	SELL	$11.45 - $13.96 $45,800 - $55,840	-4,000 Reduced 2.68%	145,300 $1.95 Million
Q3 2020 Nov 09, 2020	BUY	$10.33 - $14.49 $23,759 - $33,327	2,300 Added 1.56%	149,300 $1.56 Million
Q2 2020 Aug 05, 2020	BUY	$11.49 - $15.26 $109,155 - $144,970	9,500 Added 6.91%	147,000 $2.06 Million
Q1 2020 May 08, 2020	BUY	$8.11 - $15.23 $14,597 - $27,414	1,800 Added 1.33%	137,500 $1.62 Million
Q4 2019 Feb 06, 2020	BUY	$10.28 - $14.38 $26,728 - $37,388	2,600 Added 1.95%	135,700 $1.92 Million
Q3 2019 Nov 12, 2019	BUY	$10.05 - $14.55 $14,070 - $20,370	1,400 Added 1.06%	133,100 $1.4 Million
Q2 2019 Aug 02, 2019	BUY	$13.1 - $14.95 $36,680 - $41,860	2,800 Added 2.17%	131,700 $1.92 Million
Q1 2019 May 10, 2019	BUY	$13.69 - $20.06 $45,177 - $66,198	3,300 Added 2.63%	128,900 $1.81 Million
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $20,940 - $27,390	1,500 Added 1.21%	125,600 $2.19 Million
Q2 2018 Aug 09, 2018	SELL	$13.44 - $17.59 $120,960 - $158,310	-9,000 Reduced 6.76%	124,100 $1.71 Million
Q1 2018 May 04, 2018	BUY	$13.8 - $16.99 $102,120 - $125,725	7,400 Added 5.89%	133,100 $2.22 Million
Q3 2017 Nov 03, 2017	BUY	$12.06 - $14.12 $1.52 Million - $1.77 Million	125,700	125,700 $1.78 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Innoviva, Inc. Transaction History